Microlyte® SAM Antimicrobial Matrix
Sub-cytotoxic silver technology · applied by Apollo Wound Care
Infection and biofilm keep many chronic wounds locked in inflammation. Microlyte SAM is an ultra-thin, bioresorbable film that conforms to the wound's micro-contours for full surface contact, delivering effective antimicrobial protection using 50–100× less silver than conventional silver dressings — below the threshold that harms the very cells trying to heal. Because it resorbs, there is no dressing to peel away and no removal trauma to fragile new tissue.
The problem it exists to solve.
Conventional silver dressings solve one problem by creating another: the silver concentrations that suppress bacteria are also toxic to the fibroblasts and keratinocytes doing the healing, and peeling the dressing off tears out the fragile new tissue underneath. Microlyte breaks that trade-off — antimicrobial control at a fraction of the silver, in a film that resorbs instead of being removed. It is what we reach for when infection risk has to be managed without setting the wound back every dressing change.
Antimicrobial control without the collateral damage
Effective protection using 50–100× less silver than conventional dressings — below the level that harms the very cells rebuilding the wound.
No removal, no removal trauma
The film resorbs into the wound. There is no dressing to peel away, so new tissue is not stripped off along with it and dressing changes stop being something to brace for.
Contact across the whole wound surface
Ultra-thin and conforming, it follows the wound's micro-contours instead of bridging over them — so protection reaches the whole surface, not just the high points.
Aimed at biofilm, a top reason wounds stall
Infection and biofilm keep many chronic wounds locked in inflammation. This targets that specific blocker rather than treating the wound generically.
What the data shows.
In plain language.
- Protects stalled or infection-prone wounds without harsh silver levels.
- Resorbs into the wound — no painful dressing removal.
- Used where biofilm or infection risk is holding healing back.
FDA cleared. Clinical figures: Manning (n=32), refractory wounds, mean 40 weeks stalled. Applicability and coverage are determined at clinical assessment.
Your wound won't wait. Neither do we.
One phone call covers everything: the wound, your insurance, and the first visit date. Family members and referring providers are welcome to call on a patient's behalf.
Mon–Sat, 8am–6pm · New York City — Manhattan, Brooklyn, Queens, The Bronx & Staten Island